Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Moore

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Blood|February 1, 1989
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cellsJ Kurtzberg, T A Waldmann, M P Davey, et al.
American Journal of Clinical Pathology|March 1, 1989
Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemiaM J Borowitz, J P Gockerman, J O Moore, et al.
Journal of Neurosurgery|April 1, 1990
Treatment of patients with recurrent gliomas with cyclophosphamide and vincristineD C Longee, H S Friedman, R E Albright, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1983
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitisB F Haynes, S E Miller, T J Palker, et al.
The American Journal of Cardiology|March 1, 1995
Predictors of outcome of tricuspid valve replacement in carcinoid heart diseaseP A Robiolio, V H Rigolin, J K Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancerW P Peters, E J Shpall, R B Jones, et al.
Blood|February 1, 1997
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022J O Moore, R K Dodge, P C Amrein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
Leukemia|December 1, 2009
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosisM C Lanasa, S D Allgood, A D Volkheimer, et al.
The New England Journal of Medicine|October 6, 1994
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group BR J Mayer, R B Davis, C A Schiffer, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Blood|February 1, 1989
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cellsJ Kurtzberg, T A Waldmann, M P Davey, et al.
American Journal of Clinical Pathology|March 1, 1989
Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemiaM J Borowitz, J P Gockerman, J O Moore, et al.
Journal of Neurosurgery|April 1, 1990
Treatment of patients with recurrent gliomas with cyclophosphamide and vincristineD C Longee, H S Friedman, R E Albright, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1983
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitisB F Haynes, S E Miller, T J Palker, et al.
The American Journal of Cardiology|March 1, 1995
Predictors of outcome of tricuspid valve replacement in carcinoid heart diseaseP A Robiolio, V H Rigolin, J K Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancerW P Peters, E J Shpall, R B Jones, et al.
Blood|February 1, 1997
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022J O Moore, R K Dodge, P C Amrein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
Leukemia|December 1, 2009
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosisM C Lanasa, S D Allgood, A D Volkheimer, et al.
The New England Journal of Medicine|October 6, 1994
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group BR J Mayer, R B Davis, C A Schiffer, et al.
Pageof 8